Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

TCS' Advanced Drug Development Suite wins the India Pharma Award 2019

Posted On: 2019-12-06 19:09:24


Tata Consultancy Services' Cloud-based ADD Suite Received the Recognition for Leveraging Automation, AI and IoT to Digitally Transform Clinical Trials

Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a leading global IT services, consulting, and business solutions organization, announced that its cloud-based clinical solutions and services suite, TCS Advanced Drug Development (ADD), has won an award in the category Excellence in Ancillary Pharma Services, at the India Pharma Awards 2019.

The India Pharma Awards bring together industry pioneers and recognize outstanding examples of innovation that improve the pharma industry. TCS was recognized for its leadership in leveraging automation, artificial intelligence (AI) and IoT through its intellectual property and commercial-off-the-shelf offerings, to digitize and transform patient engagement, metadata management and regulatory submissions for life sciences organizations.

"We are building future-proof technology platforms to transform drug development by harnessing our deep knowledge of the life sciences industry, coupled with expertise in digital and AI technologies," said Debashis Ghosh, Global Head, Life Sciences and Healthcare, TCS. "This award is a testament to the advanced capabilities of our TCS ADD suite that digitally transforms clinical trials and delivers increased speed to market, improved regulatory compliance and enhanced patient experiences."

TCS ADD is a suite of cloud-based platforms adopted by 18 leading global life sciences companies to transform their product innovation initiatives. It streamlines the entire clinical R&D value chain, spanning clinical data management, metadata management, pharmacovigilance, patient engagement, clinical operations, and data analytics and insights. The suite fosters optimized study planning, accelerates study setup and execution, manages comprehensive and new data sources, derives meaningful insights, enables adherence to safety and regulatory needs, improves patient engagement, and supports adaptive trials.

The suite is powered by a cognitive engine called 'Decision Fabric' that enables the automation of complex business processes. It leverages cloud architecture and intuitive user experience design and aligns to the Good Clinical Practice guidelines and privacy regulations.

Shares of TATA CONSULTANCY SERVICES LTD. was last trading in BSE at Rs.2122.95 as compared to the previous close of Rs. 2121.5. The total number of shares traded during the day was 184863 in over 5191 trades.

The stock hit an intraday high of Rs. 2130 and intraday low of 2101. The net turnover during the day was Rs. 391025613.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Paushak Limited receives approval for expanding production capacity of Phosgene to 14,400 MTPA

Thomas Cook (India) Limited announces results for Q1 FY21

Info Edge India Ltd fixes floor price of QIP as Rs. 3177.18

LIC ups stake in YES Bank to 4.989% through market purchase

Persistent Receives 2020 Workato Partner Award for Innovation

Infosys USA certified as Great Place To Work®

Eris Lifesciences Ltd Board declares Interim Dividend of Rs. 5.50

Thomas Cook India Ltd Q1FY21 consolidated loss at Rs. 94.20 crore

PTC India Financial Services Ltd posts consolidated PAT of Rs. 26.56 crore

Sun Pharma Advanced Research Company Ltd Q1FY21 PAT at Rs. 56.69 crore

MRPL Q1 consolidated loss at Rs. 719.78 crore

ITC's Paperboards Unit at Bhadrachalam conferred with GreenCo Platinum+ rating by CII Green Business Centre for its Environmental Stewardship

NMDC registers record jump in production and sales of iron ore in July 2020

Titan Eyeplus in association with Sankara Nethralaya, Chennai launches Teleconsultation Eye care Services for its customers across the country

JSPL Felicitates its COVID-19 warriors

IndiGo repatriated 212 Indians citizens from Russia

Axis Bank Limited announces opening of QIP, floor price fixed as Rs. 442.19

Narayana Hrudalaya Ltd Q1 FY21 Consolidated operating income at Rs 3,935 mn

Tata Consumer Products Ltd announces results for the quarter ended 30th June 2020

Geojit Announces Appointment of Alice G. Vaidyan to the Board

Maruti Suzuki - Delivering sustainable growth through inclusive approach

ASM Technologies Ltd Board recommends interim dividend of Rs. 2

Digitate Launches ignio™ AI.Assurance to Transform Software Testing and Speed Up Software Release Cycles

Lupin Receives Tentative Approval for Empagliflozin Tablets

Sun Pharma launches FluGuard® (Favipiravir) in India at Rs. 35 per tablet

PI Industries Ltd posts consolidated net profit of Rs. 145.5 crore

Tata Consumer Products Ltd Q1FY20 consolidated PAT surges to Rs. 327.56 crore

Zim Laboratories Ltd Q1 consolidated PAT soars to Rs. 3.28 crore

Uniphos Enterprises Ltd posts Rs. 0.25 crore PAT in Q1FY21

Jenburkt Pharmaceuticals Ltd Q1 PAT at Rs. 1 crore

Gujarat Gas Ltd reports Rs. 59.07 crore consolidated PAT in Q1FY21

Unichem Laboratories Ltd Q1FY21 consolidated net profit at Rs. 2.43 crore

Astral Poly Technik Ltd Q1FY21 consolidated PAT falls

Tamilnadu Petroproducts Ltd Q1 consolidated PAT rises QoQ, drops YoY

Geojit Financial Services Ltd Q1FY21 consolidated net profit jumps to Rs. 23.84 crore

Century Enka Ltd posts Rs. 24.90 crore loss in Q1FY21

Vinyl Chemicals India Ltd reports higher net profit of Rs. 1.16 crore in Q1FY21

Bhansali Engineering Polymers Ltd Q1 consolidated loss at Rs. 1.38 crore

Gujarat Sidhee Cement Ltd reports Rs. 4.98 crore consolidated PAT in Q1

Atishay Ltd posts Q1FY21 net profit of Rs. 0.58 crore

Godrej Consumer Products Ltd Q1FY21 consolidated PAT rises QoQ basis

ASM Technologies Ltd Q1FY21 consolidated PAT at Rs. 3.70 crore

Igarashi Motors India Ltd Q1FY21 loss at Rs. 10.52 crore

HIKAL Ltd Q1FY21 consolidated PAT at Rs. 15 crore

Varun Beverages Ltd Board declares Interim Dividend of Rs. 2.50 for CY2020

Deccan Cements Ltd board to announce Q1 results on Aug 14, 2020

Berger Paints India Ltd board to approve quarterly results on Aug 14, 2020

Marksans Pharma Ltd Q1FY21 Revenue at Rs. 331.3 Cr

Ashok Leyland subsidiary Optare delivers first of 21 battery-electric Metrodecker EV with First York

Ashwini Kumar Tewari Takes Charge as The Managing Director and CEO of SBI Card







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019